SEP 11, 2026 · PHASE 2 TRIAL
A Study of Sotorasib in People With Non-Small Cell Lung Cancer
ClinicalTrials.gov
This is a Phase 2 clinical trial registration with no posted results; it describes a planned study of sotorasib in treatment-naive advanced NSCLC with KRAS G12C mutation, currently recruiting.
Reported
Planned enrollment39
PhasePHASE 2
Primary outcome measureResponse to therapy, within 6 months of the…